Article Details

Cantor Fitzgerald Keeps a Buy Rating on PTC Therapeutics (PTCT) and $61 Target; Shorts at ...

Retrieved on: 2019-02-28 19:23:51

Tags for this article:

Click the tags to see associated articles and topics

Cantor Fitzgerald Keeps a Buy Rating on PTC Therapeutics (PTCT) and $61 Target; Shorts at .... View article details on hiswai:

Excerpt

<div><b>Anaplan</b> Inc (NYSE:PLAN) had an increase of 82.84% in short interest. PLAN's SI was 921,700 shares in March as released by FINRA. Its up 82.84% ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up